CD4 and myeloid sarcoma: A slightly higher combined expression of three dynamic markers on CD4+ cTfh1 cells following first vaccination was observed in MS-OCR patients compared to HCs, whereas the combined expression of multiple dynamic markers in RA-MTX patients was slightly lower compared to HCs (Figure 3f and Figure 3—figure supplement 1d).